Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FZS80
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $32,499.90 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 17, 2025, for Stelara 90 mg/ml syringes. The contract carries an ultimate completion date of October 8, 2025, and utilizes no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities.
Stelara, a biologic medication used to treat autoimmune conditions, represents one of many specialized pharmaceutical products that DMS Pharmaceutical Group supplies to Department of Defense healthcare sites nationwide. The company's established role as a crucial supplier in the federal pharmaceutical supply chain is evidenced by its consistent procurement success across diverse product categories including prescription medications, biologics, vaccines, and medical consumables. This award demonstrates the DLA's ongoing reliance on DMS Pharmaceutical Group to fulfill critical pharmaceutical supply requirements for military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FZS80?
SPE2DB25FZS80 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FZS80 worth?
The government has obligated $32,500 on SPE2DB25FZS80.
Is contract SPE2DB25FZS80 an order under another contract?
Yes. SPE2DB25FZS80 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS80 competed?
The extent of competition for SPE2DB25FZS80 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award